M Vax

Related by string. MVax * Med . Ming . MD . MS . Ms . med . M. . m . Md . ms . MED : MS RD . MD MPH associate professor . Club Med . Gov. M. Jodi . #,# m steeplechase . Thomas M. Menino . #,# m [003] . Moham med . pre med . M. Night Shyamalan . MD associate professor / VAX . vax : VAX VacationAccess . TSX VENTURE VAX . anti vax . VAX VMS . VAX D . RECALL VAX TM . RECALL VAX vaccine . DEC VAX . VAX VacationAccess R . RECALL VAX * *

Related by context. Frequent words. (Click for all words.) 62 TELCYTA 62 eniluracil 61 ADVEXIN 61 BiovaxID 60 CoFactor 60 thymalfasin 60 immunomodulator 60 drug conjugate 60 TG# [001] 59 Phase 2a trial 59 BiTE antibody 59 FavId 59 AP# [003] 59 humanized anti 59 BAY #-# 58 confirmatory Phase III 58 HuMax CD# 58 Allovectin 7 R 58 IMGN# 58 orally bioavailable 58 SCH # 58 INCB# [002] 58 immunotherapeutic 58 decitabine 58 OXi# 58 methylnaltrexone 58 PXD# 58 perifosine 58 relapsed refractory multiple myeloma 58 phase IIa 57 radiolabeled 57 dose escalation trial 57 PF # [001] 57 injectable formulation 57 Reolysin 57 romidepsin 57 HGS ETR1 57 dose cohorts 57 topical formulation 57 Cethrin 57 phase IIb 57 TOCOSOL Paclitaxel 57 MAb 57 TREANDA 57 HspE7 57 IMC A# 56 anticancer agent 56 Icatibant 56 Phase Ib 56 GRN#L 56 T DM1 56 TORISEL 56 Phase 1b clinical 56 ZYBRESTAT 56 administered subcutaneously 56 Phase 1b trial 56 Zelrix 56 CYT# 56 humanized monoclonal antibody 56 Taxotere ® 56 nab paclitaxel 56 Phase IIa trial 56 Gabapentin GR 56 TYKERB 56 octreotide 56 Gemcitabine 56 biologic therapy 55 Neuradiab 55 pivotal Phase III 55 CYC# 55 Asentar 55 MAP# 55 Genasense 55 PS# [001] 55 Phase III pivotal 55 MGCD# [001] 55 axitinib 55 Phase 1a 55 ofatumumab 55 Bortezomib 55 exon skipping 55 Trastuzumab 55 relapsed refractory 55 investigational 55 Belinostat 55 DB# [003] 55 anti TNF alpha 55 SinuNase 55 dose escalation 55 Phase III clinical trials 55 Amigal 55 DAVANAT ® 55 GVAX immunotherapy 54 ATryn R 54 HCV protease inhibitor 54 immune modulation 54 Synavive 54 Erlotinib 54 MOZOBIL 54 Phase 2b clinical 54 Phase IIa clinical

Back to home page